RANI compared with SEPN: revenue, margins and what each company keeps, and the suppliers and customers both name

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

SEPNSepterna, Inc.

Mkt capRevenueRevenue

Compare

RANIRani Therapeutics Holdings, Inc.

SEPNSepterna, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RANI 6

—Celltrionunlistedsupplier

—Chugai Pharmaceuticalunlistedsupplier

—ProGenunlistedsupplier

—ICLunlistedsupplier

2 more · RANI chain ›

Shared 0

No shared counterparties.

Only SEPN 2

VRTXVertex Pharmaceuticals Incorporated ("Vertex")customer

—Novounlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

RANIRani Therapeutics Holdings, Inc.

0.60· pre 0.60· delayed

Mkt cap$82.2MRevenue$2MQ2 FY26Revenue—

SEPNSepterna, Inc.

43.98· pre 43.98· delayed

Pre-marketOct 30 '26delayed

Mkt cap$2.0BRevenue$27MQ2 FY26Revenue$46MFY25

Compare

Pre-marketOct 30 '26delayed

RANIRani Therapeutics Holdings, Inc.

SEPNSepterna, Inc.

0.60pre 0.60delayed

Price

43.98pre 43.98delayed

$82.2M

Mkt cap

$2.0B

Q2 FY26$2M

Revenue

$27MQ2 FY26

—

Revenue

$46MFY25

RANI0.60vsSEPN43.98Pre-marketOct 30 '26delayed